| Dr Genevieve Nwigwe, MD | |
|
1700 Myrtle Ave, Plainfield, NJ 07063-1000 | |
| (908) 753-6401 | |
| (908) 226-6743 |
| Full Name | Dr Genevieve Nwigwe |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 1700 Myrtle Ave, Plainfield, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881968261 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA08648800 (New Jersey) | Primary |
| Entity Name | American Current Care Of New Jersey Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609044999 PECOS PAC ID: 1153461264 Enrollment ID: O20091222000279 |
News Archive
Like private investigators on a stake out, St. Jude Children's Research Hospital scientists used patience and video surveillance-like tools to identify cells that trigger blood cell development.
Although the researchers found that the rats tested negative for the virus, they say it is important to continue monitoring animals for the virus as it mutates, making previously resistant species susceptible to infection.
An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).
BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.
› Verified 7 days ago
| Entity Name | The Md Telemedicine Network Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205599453 PECOS PAC ID: 2961891759 Enrollment ID: O20220510001329 |
News Archive
Like private investigators on a stake out, St. Jude Children's Research Hospital scientists used patience and video surveillance-like tools to identify cells that trigger blood cell development.
Although the researchers found that the rats tested negative for the virus, they say it is important to continue monitoring animals for the virus as it mutates, making previously resistant species susceptible to infection.
An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).
BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Genevieve Nwigwe, MD 1700 Myrtle Ave, Plainfield, NJ 07063-1000 Ph: (908) 753-6401 | Dr Genevieve Nwigwe, MD 1700 Myrtle Ave, Plainfield, NJ 07063-1000 Ph: (908) 753-6401 |
News Archive
Like private investigators on a stake out, St. Jude Children's Research Hospital scientists used patience and video surveillance-like tools to identify cells that trigger blood cell development.
Although the researchers found that the rats tested negative for the virus, they say it is important to continue monitoring animals for the virus as it mutates, making previously resistant species susceptible to infection.
An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).
BioRx, a specialty pharmacy company, has received limited distribution rights from Baxter International Inc. for a new drug, GLASSIA™ [Alpha 1-Proteinase Inhibitor (Human)], the first and only liquid, ready-to-use treatment for alpha-1 antitrypsin deficiency (AATD) in the United States. AATD is a genetic disorder that causes low levels of alpha 1-antitrypsin, resulting in emphysema. AATD is also referred to as "genetic" or "congenital" emphysema.
› Verified 7 days ago
Saleem Husain, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1314 Park Ave, Suite 9, Plainfield, NJ 07060 Phone: 908-222-8970 Fax: 908-222-8762 | |
Eva Besserman, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Muhlenberg Regional Medical Center, Park Ave. & Randolph Rd., Plainfield, NJ 07061 Phone: 908-668-2228 Fax: 908-226-4543 | |
Dr. Harsha Tripathi, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 Myrtle Ave, Plainfield, NJ 07063 Phone: 908-753-6401 Fax: 908-226-6743 | |
Dr. David Alan Goldenberg, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1165 Park Ave, Plainfield, NJ 07060 Phone: 908-754-2992 | |
Dr. Susan Walsh, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1700 Myrtle Ave, Plainfield, NJ 07063 Phone: 908-753-6401 | |
Dr. Padmaja Isukapalli, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1024 Park Ave, Suite 6 A, Plainfield, NJ 07060 Phone: 908-222-8400 Fax: 908-222-8402 | |
Dr. Janet C Lin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: Muhlenberg Regional Medical Center, Park Ave And Randolph Rd, Plainfield, NJ 07061 Phone: 908-668-2985 Fax: 908-226-4543 |